DP-21-001 Maryland Pregnancy Risk Assessment Monitoring System (PRAMS)
DP-21-001 Maryland Pregnancy Risk Assessment Monitoring System (PRAMS)
批准号:
10581714
负责人:
Shelly Choo
金额:
$17.5万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-01 至 2026-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Pregnancy Risk Assessment Monitoring System (PRAMS) in Maryland
Executive Summary, July 2020
Background-The Maternal and Child Health Bureau and the Vital Statistics
Administration have worked jointly to implement the Maryland PRAMS project since
2000 through a cooperative agreement with the Centers for Disease Control and
Prevention (CDC). PRAMS surveys mothers 2-9 months after delivery about factors
before, during, and shortly after pregnancy that may have an impact on pregnancy
outcome. The program has also proven its capacity to implement survey supplements on
emerging issues including the influenza vaccine, Zika, disability, and opioid use.
The Maryland PRAMS survey booklet is sent monthly to a sample of new mothers
along with an incentive (manicure file). The survey questionnaire, as well as other
PRAMS materials, is available in both English and Spanish. Each mother is sent up to
three surveys followed by a telephone interview if no written surveys have been
returned. A $100 gift card is given out monthly to a mother chosen randomly who has
completed the mail or phone survey. Maryland currently utilizes a stratified random
sample based on infant birth weight (over-selecting mothers who have delivered a low
birth weight infant under <2500 grams).
Program Features-Maryland PRAMS data are analyzed annually and currently
include reports from 2001 to 2017 birth years. Focus Briefs on various topics are posted
on the PRAMS website at www.marylandprams.org. Human Subjects Training occurs
annually for all PRAMS staff and was last completed in July 2020.
Number of Mothers Served-Approximately 2,000 new mothers are surveyed
annually. As of June 2020, 44,714 new mothers in Maryland have been mailed the
PRAMS survey since its inception. Annual weighted response rates from 2001-2017
births have met or exceeded the threshold.
Budget-Maryland PRAMS is currently funded at $172,500 annually ($157,500 in core
funding and $15,000 in supplemental disability funding). We are currently in year five of
a five year cycle. This competitive application is for year one of the next 5 year grant
cycle. We will be requesting the ceiling award amount of $175,000.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maryland Pregnancy Risk Assessment Monitoring System (PRAMS)
-
批准号:10228793
-
项目类别:
-
资助金额:$16.0万
-
财政年份:2021
-
负责人:Shelly Choo
-
依托单位:
Maryland Pregnancy Risk Assessment Monitoring System (PRAMS)
-
批准号:10386757
-
项目类别:
-
资助金额:$16.0万
-
财政年份:2021
-
负责人:Shelly Choo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
LncRNA HNRNPA1P21通过诱导M2极化和PD-L1表达促进肺癌进展的机制研究
-
批准号:JCZRLH202601430
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
M2型巨噬细胞来源外泌体中miRNA-21下调KLF5抑制心肌梗死中脂毒性的作用及机制研究
-
批准号:2026JJ81356
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭漪
-
依托单位:
LINC00472通过miR-21-5p调节GLIS2和SMAD7的表达在胆道闭锁肝纤维化的作用及机制研究
-
批准号:2026JJ82157
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:许光
-
依托单位:
Tfh/IL-21信号轴与M2巨噬细胞交互对话在低氧性肺动脉高压中的作用及机制研究
-
批准号:2026JJ50593
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李城
-
依托单位:
基于FGF21/FGFR1轴探究鼠尾草酸甲酯改善肝细胞胰岛素抵抗的作用机制
-
批准号:2026JJ80987
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:江军仪
-
依托单位:
INHBA通过TRIM21/SLC25A10上调琥珀酸诱导结直肠癌免疫治疗耐药的分子机制研究
-
批准号:2026JJ50311
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:袁霞
-
依托单位:
NUDT21介导TRIM35选择性多聚腺苷酸化调控肺腺癌恶性进展的机制研究
-
批准号:2026JJ82175
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨德松
-
依托单位:
ADAM17通过调控MMP21促进肝细胞癌进展和M2型巨噬细胞极化
-
批准号:2026JJ82501
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:向宇琦
-
依托单位:
TRIM21介导PKM2 K166位点泛素化在黑色素瘤免疫逃逸中的作用及机制研究
-
批准号:2026JJ60582
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱素锶
-
依托单位:
基于TBX21/EP300/PFKL正反馈环路黄芩苷靶向小胶质细胞组蛋白乳酰化改善ICH后继发性脑损伤的机制研究
-
批准号:2026JJ60594
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邹智超
-
依托单位: